Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

about

In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes.Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.

P2860

Q55032901-5786CE69-F7D2-423B-B38C-CFDA1C338956 Q55449228-D4E654FC-9921-4ED2-98F9-414A5A62B56D

P2860

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

Item

http://www.wikidata.org/entity/Q47819341

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@en

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@nl

type

Item

label

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@en

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@nl

prefLabel

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@en

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@nl

P1476

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

@en

P2093

Claudia Lanvers-Kaminsky

http://www.w3.org/2001/XMLSchema#string

Giuliano Ciarimboli

http://www.w3.org/2001/XMLSchema#string

P2860

New developments in aminoglycoside therapy and ototoxicity

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations

Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.

The unique electrical properties in an extracellular fluid of the mammalian cochlea; their functional roles, homeostatic processes, and pathological significance.

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Cellular processing of platinum anticancer drugs

Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.

P304

1683-1695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2017-0125

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29173064

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

about

P2860

P2860

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698